A Q&A with Kristen Schneider Boerger and Morgan Bertram on service, leadership, and advancing The Blood & Tissue Center Foundation. The 2026 Foundation Chairs, Kristen
2026 Red & White Ball Builds Momentum for BioBridge Global’s Future Building on the success of the 2025 Red & White Ball, the goal for
The 2026 Foundation Chairs, Kristen Schneider Boerger and Morgan Bertram, share their vision for momentum, leadership, and continued impact at The Blood & Tissue Center
Program milestone highlights lifesaving impact of civilian prehospital whole blood in San Antonio and beyond On Thursday, Jan. 29, South Texas Blood & Tissue celebrated
Advanced Therapies Week 2026 BBG Advanced Therapies is heading to Advanced Therapies Week 2026, traveling from San Antonio to San Diego with our Mobile Leukapheresis
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Before sunrise on MLK Day, more than 50 BioBridge Global staff members gathered in downtown San Antonio to take part in the city’s annual MLK
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Potency assays are a cornerstone of effective cell therapies, but they can also be a source of delay during development. We spoke with Scott Jones,
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Medicare’s New Math on CAR-T Reimbursement Changes: Who Wins, Who Hurts, and What Could Break For a decade, CAR-T has been the ultimate “no-brainer” innovation